 | Articles: Drug Trials |
New Analyses of Pivotal Phase 3 Study of ERBITUX(R) Demonstrate Enhanced Efficacy in First-Line Metastatic Colorectal Cancer Patients with Wild-Type K-Ras Biomarker
Corporate News Releases, 06/03/08
New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens
Corporate News Releases, 06/03/08
Phase III Study of Abbott's Investigational TriLipix(TM) in Combination With AstraZeneca's CRESTOR(R) Meets Primary Endpoints on Key Lipids
Corporate News Releases, 06/03/08
 | | Sponsor |
Genmab Initiates Zalutumumab Combination Study in Colorectal Cancer
Corporate News Releases, 06/03/08
Rivaroxaban Superior to U.S.-Approved Dosing Regimen for Enoxaparin in Reducing Venous Blood Clots after Total Knee Replacement Surgery in Pivotal Phase III Trial
Corporate News Releases, 06/03/08
Updated Data from Ongoing Phase 3 Trials Support the Continued Study of Vectibix(R) (panitumumab) in Combination with Standard Chemotherapy
Corporate News Releases, 06/03/08
Lilly Submits Cymbalta Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Lilly, 06/02/08
Strativa Pharmaceuticals Announces Preliminary Results from ONCONASE(R) Phase IIIb Clinical Trial
PharmiWeb, 06/02/08
Genmab announces updates on phase III cancer studies
Genmab, 06/02/08
Data from Pivotal Phase III Studies of Gilead's Letairis(R) (ambrisentan) for Pulmonary Arterial Hypertension (WHO Group 1) in Patients with WHO Functional Class II or III Symptoms Published in Circulation
Corporate News Releases, 06/02/08
|
 Receive daily email updates on Drug Trials
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
 |
|
| Read a Different Specialty |
 |
|
|
|
|
| Profession Index |
|
|
|
|
|
|
 |
| Sponsor |
|
